RT Journal Article
SR Electronic
T1 Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2019
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.01.20087114
DO 10.1101/2020.05.01.20087114
A1 Gaibazzi, Nicola
A1 Martini, Chiara
A1 Mattioli, Maria
A1 Tuttolomondo, Domenico
A1 Guidorossi, Angela
A1 Suma, Sergio
A1 Dey, Damini
A1 Palumbo, Anselmo
A1 De Filippo, Massimo
YR 2020
UL http://medrxiv.org/content/early/2020/05/17/2020.05.01.20087114.abstract
AB Aims The in-hospital mortality rate of the coronavirus disease 2019 (COVID-19) is higher in case of myocardial injury, but the underlying mechanism is unknown. We conducted a study on COVID-19 patients to determine the association of the extent of lung disease or coronary artery chest computed tomography (HRCT) variables, the Agatston coronary calcium score (CCS) and peri-coronary adipose tissue (PCAT) attenuation, with mortality.Methods and results A single-center retrospective case series of 500 consecutive patients was collected, with chest HRCT performed as a gatekeeping-strategy in the workup of patients admitted for suspected COVID-19 to our emergency department in Northern Italy, from March 5 to March 15, 2020. Patients with laboratory-confirmed COVID-19 formed the final study group. The endpoint was in-hospital mortality at the time of final follow-up (March 30, 2020). Demographic, clinical, laboratory and HRCT data were collected from hospital electronic records, and HRCT features (CCS and PCAT attenuation) were measured post-hoc from HRCT images.Among 500 patients with suspected COVID-19, 279 had laboratory-confirmed COVID-19 and formed the study group. Among them, 170 patients (61%) were discharged alive and 109 (39%) died. Comparing patients discharged alive with patients who died, the median age was 65 vs 77 (p<0.001), with males 56% vs 68% (p=0.061), prior cardiovascular disease 9% vs 24% (p=0.001), median D-dimer 723 vs 1083 ng/ml (p<0.001), median C-reactive protein 78 vs 148 mg/L (p<0.001), the mean CCS 17 vs 189 (p<0.001) and the median PCAT attenuation −76.4 HU vs −68.6 HU (p<0.001). In multivariable analysis, only age (p<0.001), D-dimer (p=0.041), C-reactive protein (p=0.002), HRCT lung disease extent (p=0.002) and peri-coronary adipose tissue attenuation (p<0.001) – not the Agatston CCS – were independently associated with mortality.Conclusions Our study suggests that higher mortality in COVID-19 may be at least partly mediated by coronary artery inflammation, rather than subclinical coronary artery disease extent.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe received no funding regarding the work presentedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred to in the manuscript are available in the identified form, upon reasonable and motivated request to the corresponding author.